Condition: Choroidal Melanoma · Indeterminate Lesions · Uveal Melanoma · Sponsor: Aura Biosciences
To assess subject-centric real-world evidence of QoL outcomes in subjects enrolled in the global Phase 3 AU-011-301 clinical trial.
This description comes directly from the study's public registry record.
Medical Monitor · 617-500-8864 · clinical@aurabiosciences.com
Always discuss trial participation with your own doctor first.
| Eye Research Australia | East Melbourne, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07421739